Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jonathan L Spallino"'
Autor:
Mary L. Vallecillo-Zúniga, Peter Daniel Poulson, Jacob S. Luddington, Christian J. Arnold, Matthew Rathgeber, Braden C. Kartchner, Spencer Hayes, Hailie Gill, Jonard C. Valdoz, Jonathan L. Spallino, Seth Garfield, Ethan L. Dodson, Connie M. Arthur, Sean R. Stowell, Pam M. Van Ry
Publikováno v:
Cells, Vol 10, Iss 11, p 3210 (2021)
Two of the main pathologies characterizing dysferlinopathies are disrupted muscle membrane repair and chronic inflammation, which lead to symptoms of muscle weakness and wasting. Here, we used recombinant human Galectin-1 (rHsGal-1) as a therapeutic
Externí odkaz:
https://doaj.org/article/91776f7c4f7e4124ac9a89b01315ee53
Autor:
Hailie N. Gill, Mary L. Vallecillo-Zúniga, Matthew F. Rathgeber, Christian J Arnold, Spencer Hayes, Pam M. Van Ry, Braden C. Kartchner, Peter Daniel Poulson, Ethan L. Dodson, Jacob S. Luddington, Seth R. Garfield, Sean R. Stowell, Connie M Arthur, Jonathan L Spallino, Jonard Corpuz Valdoz
Publikováno v:
Cells
Volume 10
Issue 11
Cells, Vol 10, Iss 3210, p 3210 (2021)
Volume 10
Issue 11
Cells, Vol 10, Iss 3210, p 3210 (2021)
Two of the main pathologies characterizing dysferlinopathies are disrupted muscle membrane repair and chronic inflammation, which lead to symptoms of muscle weakness and wasting. Here, we used recombinant human Galectin-1 (rHsGal-1) as a therapeutic